CHIEF EXECUTIVE OFFICER
Thu, Nov 6, 2025
Nov 6
returned securities to the issuer in DAWN
244,000 shares @ $0.00
Decreased holdings by -100.00%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
DAWNDay One Biopharmaceuticals, Inc.
HealthcareBiotechnology